Navigation Links
Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College
Date:1/14/2014

VALHALLA, N.Y., Jan. 14, 2014 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, announced today the relocation of its corporate headquarters to Valhalla, NY as of January 15, 2014 and expanded lease agreement for additional laboratory space at New York Medical College.

Oligomerix, which is focused on the development of small molecule drugs aimed specifically at inhibiting tau aggregation at the earliest steps of tau self-association into toxic oligomers in neurons, has continued to successfully advance its research, resulting in the need to add staff and expand its office and lab space.

"We're extremely encouraged by the preclinical data we've observed in our lead small molecule program, and are eager to continue our research in this space," stated James Moe, Ph.D., MBA, President and CEO of Oligomerix.  "As New York Medical College is already providing space for in vivo mouse studies for our lead compound, we believe the decision to move and expand Oligomerix's corporate headquarters will benefit the company's logistical needs."

Oligomerix recently announced the appointment of James Hendrix, Ph.D., as the company's Senior Director of Chemistry, and plans to potentially recruit up to five employees in 2014.

ABOUT OLIGOMERIXOligomerix, Inc. is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. Founded in 2006, the Company is headquartered in Valhalla, NY and is carrying out its in vivo studies at New York Medical College.  The Company is seeking strategic partners to help accelerate
'/>"/>

SOURCE Oligomerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oligomerix Awarded Phase IIB Grant From the NIH to Discover Drugs that Inhibit Alzheimers Disease Progression
2. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
3. ImmusanT Relocates Offices to State-of-the-Art Innovation Facility
4. Sysmex America Relocates Corporate Headquarters
5. HemoShear Relocates and Expands Operations to Historic Martha Jefferson Property in Charlottesville, Virginia
6. Growth Fuels Expansion As PendoTECH Relocates New Jersey Headquarters
7. Optimal Radiology Relocates Headquarters to Nashville
8. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
9. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
10. Survey Shows eContent Critical to Corporate Strategies
11. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... BOCA RATON, Fla. , July 29, 2015 ... immediate launch of Azelastine HCl Nasal Solution, 0.1%. The ... this Abbreviated New Drug Application (ANDA), which is ... Meda Pharmaceuticals. Azelastine hydrochloride nasal solution (nasal spray) ... on June 2015 IMS Health sales data.  Azelastine ...
(Date:7/29/2015)... , July 29, 2015 ... research report "Global Industry Insight: Microfluidic Devices ... market overview, trends, DRO analysis, market segmentation, ... developments, competitive scenario and top competitor profiles. ... Microfluidic devices  ...
(Date:7/29/2015)... , July 29, 2015 Commenting ... transaction closed, CFO Simon Dingemans reveals sales ... are performing in line with expectations. Ahead of a ... to sustainable innovation. The interview and transcript ... MerchantCantos produces in-depth interviews, documentaries and webcasts with senior ...
Breaking Medicine Technology:Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5
... The drug imatinib,mesylate, more commonly known as Gleevec(R), ... with an advanced form of chronic myeloid leukemia,(CML), according ... of the American Society of Hematology., A team ... drug,s,creator, Brian Druker, MD, followed 454 patients with chronic-phase ...
... ActivBiotics, Inc. today,announced the results of its ... rifalazil in the treatment of intermittent claudication,associated ... demonstrated,that treatment for two months with the ... significant improvement in walking distance,claudication onset times, ...
Cached Medicine Technology:Leukemia Drug Proves Safe and Effective Over the Long Term 2Rifalazil Trial (PROVIDENCE-1) Fails to Provide Significant Clinical Benefit in Patients With Peripheral Arterial Disease 2Rifalazil Trial (PROVIDENCE-1) Fails to Provide Significant Clinical Benefit in Patients With Peripheral Arterial Disease 3
(Date:7/29/2015)... ... July 29, 2015 , ... The healthcare analytics market is ... region. Factors such as the rising pressure to curb healthcare costs, big data ... venture capital investments are driving market growth. Check 149 data tables & 57 ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business on ... directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same gene, ... the National academy of Sciences, and has given researchers inklings to explore Rsu1 in ...
(Date:7/29/2015)... ... 2015 , ... According to the Miami Herald on July 18th ... health disorders. Acu-detox may begin taking off in the South Florida community as more ... Although acupuncture is not a new practice, it is not widely used, but has ...
(Date:7/29/2015)... ... 29, 2015 , ... San Fernando Valley skin doctor , Dr. Peyman ... only, patients can get the complete treatment process with a 10 percent discount on ... treatment and have loose or sagging skin. , As the only non-surgical procedure ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement in bringing ... growth companies and is led by a group of experienced investors, has tapped into ... with their dollars to be a part of the fund. The Sofia Fund ...
Breaking Medicine News(10 mins):Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Sofia Fund Surpasses Investor Goals 2
... test to assess chest pain is accurate in more rapid ... a heart attack. It can be caused by indigestion or ... a medical emergency, and a series of tests is given ... a heart attack.// , These tests normally take a ...
... be better than white at fending off fungi and ... it could explain why dark skin evolved in humans ... theory on why darker skin prevailed in some areas ... melanin in darker skin protects against cancer and sunburn ...
... Duke University in the United States, depression increases the ... depression and coronary artery disease is well established and ... 357 patients diagnosed with heart failure for depression. They ... suffering from major depression. Patients who were not depressed ...
... in this week’s British Medical Journal shows that bacteria with ... for ear infections can be used successfully and may help ... one of the most common bacterial infections in young children, ... is caused by the spread of Streptococcus pneumoniae and other ...
... Britain examining the relationship between increasing rates of testicular ... have infertility problems have an increased risk of developing ... of the British Medical Journal (BMJ), the study found ... the subsequent risk of testicular cancer, with men in ...
... factor for most cancers, says a Stanford University Medical Centre ... have a genetic component than those diagnosed later. , , Rare ... familial than breast and lung cancer.// The model assumed that ... of several relatively rare genes. , , The new model ...
Cached Medicine News:
... Since its introduction to the market, the ... has proven itself as a highly efficient ... fields of urology and gastroenterology. The new ... been technically further developed and improved in ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
One piece, 100% fused silica construction offers low scatter and high efficiency...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
Medicine Products: